Peregrine Capital Management LLC Dexcom Inc Transaction History

Peregrine Capital Management LLC

$3.18 Billion
Q4 2024

A detailed history of Peregrine Capital Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Peregrine Capital Management LLC holds 588,748 shares of DXCM stock, worth $53.4 Million. This represents 1.44% of its overall portfolio holdings.

Number of Shares

588,748

Previous 617,883 4.72%

Holding current value

$53.4 Million

Previous $41.4 Million 10.57%

% of portfolio

1.44%

Previous 1.3%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$65.68 - $81.01 $1.91 Million - $2.36 Million	-29,135 Reduced 4.72%	588,748 $45.8 Million
Q3 2024 Oct 24, 2024	SELL	$64.0 - $116.06 $4.52 Million - $8.2 Million	-70,619 Reduced 10.26%	617,883 $41.4 Million
Q2 2024 Jul 29, 2024	BUY	$110.31 - $140.45 $1.55 Million - $1.97 Million	14,031 Added 2.08%	688,502 $78.1 Million
Q1 2024 Apr 26, 2024	SELL	$114.22 - $140.1 $1.29 Million - $1.59 Million	-11,336 Reduced 1.65%	674,471 $93.5 Million
Q4 2023 Jan 26, 2024	BUY	$75.49 - $124.16 $3.1 Million - $5.09 Million	41,014 Added 6.36%	685,807 $85.1 Million
Q3 2023 Oct 19, 2023	BUY	$86.06 - $137.93 $5.74 Million - $9.2 Million	66,703 Added 11.54%	644,793 $60.2 Million
Q2 2023 Jul 26, 2023	SELL	$112.47 - $130.98 $717,108 - $835,128	-6,376 Reduced 1.09%	578,090 $74.3 Million
Q1 2023 Apr 26, 2023	BUY	$104.0 - $122.92 $724,568 - $856,383	6,967 Added 1.21%	584,466 $67.9 Million
Q4 2022 Jan 10, 2023	BUY	$84.98 - $122.67 $749,268 - $1.08 Million	8,817 Added 1.55%	577,499 $65.4 Million
Q3 2022 Oct 26, 2022	SELL	$76.35 - $94.18 $597,744 - $737,335	-7,829 Reduced 1.36%	568,682 $45.8 Million
Q2 2022 Jul 20, 2022	BUY	$67.99 - $132.89 $28.9 Million - $56.4 Million	424,436 Added 279.1%	576,511 $43 Million
Q1 2022 Apr 27, 2022	SELL	$94.08 - $130.2 $1.28 Million - $1.77 Million	-13,604 Reduced 8.21%	152,075 $77.8 Million
Q4 2021 Jan 31, 2022	BUY	$129.87 - $162.82 $1.83 Million - $2.3 Million	14,097 Added 9.3%	165,679 $89 Million
Q3 2021 Nov 02, 2021	SELL	$106.71 - $143.18 $112,899 - $151,484	-1,058 Reduced 0.69%	151,582 $82.9 Million
Q2 2021 Aug 03, 2021	BUY	$80.99 - $107.93 $561,503 - $748,278	6,933 Added 4.76%	152,640 $65.2 Million
Q1 2021 May 11, 2021	BUY	$84.79 - $104.74 $3.11 Million - $3.85 Million	36,732 Added 33.71%	145,707 $52.4 Million
Q4 2020 Jan 19, 2021	BUY	$78.0 - $104.5 $1.08 Million - $1.44 Million	13,795 Added 14.49%	108,975 $40.3 Million
Q3 2020 Oct 20, 2020	BUY	$95.51 - $112.95 $55,013 - $65,059	576 Added 0.61%	95,180 $9.81 Million
Q2 2020 Jul 30, 2020	SELL	$62.68 - $105.34 $549,139 - $922,883	-8,761 Reduced 8.48%	94,604 $9.59 Million
Q1 2020 Apr 17, 2020	BUY	$47.79 - $75.63 $583,707 - $923,744	12,214 Added 13.4%	103,365 $6.96 Million
Q4 2019 Jan 16, 2020	SELL	$36.62 - $57.29 $7.32 Million - $11.4 Million	-199,800 Reduced 68.67%	91,151 $4.99 Million
Q3 2019 Oct 16, 2019	BUY	$35.53 - $43.8 $3.03 Million - $3.73 Million	85,246 Added 41.44%	290,951 $10.9 Million
Q2 2019 Jul 18, 2019	SELL	$27.84 - $38.92 $676,706 - $946,028	-24,307 Reduced 10.57%	205,705 $0
Q1 2019 Apr 12, 2019	SELL	$28.07 - $38.18 $301,022 - $409,442	-10,724 Reduced 4.45%	230,012 $0
Q4 2018 Jan 17, 2019	BUY	$26.99 - $37.37 $532,269 - $736,973	19,721 Added 8.92%	240,736 $7.21 Million
Q3 2018 Oct 18, 2018	SELL	$23.35 - $36.72 $1.68 Million - $2.63 Million	-71,740 Reduced 24.51%	221,015 $0
Q2 2018 Jul 12, 2018	BUY	$17.54 - $25.22 $256,715 - $369,119	14,636 Added 5.26%	292,755 $0
Q1 2018 Apr 16, 2018	SELL	$13.06 - $18.54 $125,519 - $178,187	-9,611 Reduced 3.34%	278,119 $0
Q4 2017 Jan 24, 2018	SELL	$11.12 - $15.38 $1.2 Million - $1.66 Million	-107,725 Reduced 27.24%	287,730 $0
Q3 2017 Oct 25, 2017	BUY	$11.36 - $18.98 $4.49 Million - $7.51 Million	395,455	395,455 $0

Others Institutions Holding DXCM

# of Institutions

1,080

Shares Held

351M

Call Options Held

8.45M

Put Options Held

5.75M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $35.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Account

Peregrine Capital Management LLC Dexcom Inc Transaction History